CoVance Inc. is developing the Elisa Test Kit for the Tk-1 for Biopulse International Inc. and BYU...joint effort. Follow the money....Roth Capital Partners gave $3,500,000 to Biopulse not some BYU private small company.. Everyone from CEO to board of directors got shares of Biopulse.... If Covance Inc. and Biopulse can't produce a Elisa test kit then Celtic Biotech might get it back..which is really BYU. In at least in the next 8 years...we should see somekind of Tk-1 test kit... Just store your Biopulse shares away..... 8 years is short....